297 related articles for article (PubMed ID: 22342162)
1. Central nervous system inflammation in disease related conditions: mechanistic prospects.
Fung A; Vizcaychipi M; Lloyd D; Wan Y; Ma D
Brain Res; 2012 Mar; 1446():144-55. PubMed ID: 22342162
[TBL] [Abstract][Full Text] [Related]
2. Tight junctions in brain barriers during central nervous system inflammation.
Coisne C; Engelhardt B
Antioxid Redox Signal; 2011 Sep; 15(5):1285-303. PubMed ID: 21338320
[TBL] [Abstract][Full Text] [Related]
3. Inflammation in the nervous system--physiological and pathophysiological aspects.
Schultzberg M; Lindberg C; Aronsson AF; Hjorth E; Spulber SD; Oprica M
Physiol Behav; 2007 Sep; 92(1-2):121-8. PubMed ID: 17597167
[TBL] [Abstract][Full Text] [Related]
4. Inflammasome signaling at the heart of central nervous system pathology.
Chakraborty S; Kaushik DK; Gupta M; Basu A
J Neurosci Res; 2010 Jun; 88(8):1615-31. PubMed ID: 20127816
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid system in targeting inflammatory neurodegenerative diseases.
Centonze D; Finazzi-Agrò A; Bernardi G; Maccarrone M
Trends Pharmacol Sci; 2007 Apr; 28(4):180-7. PubMed ID: 17350694
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and gliosis in neurological diseases--clinical implications.
Członkowska A; Kurkowska-Jastrzębska I
J Neuroimmunol; 2011 Feb; 231(1-2):78-85. PubMed ID: 20943275
[TBL] [Abstract][Full Text] [Related]
7. The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine CNS diseases.
Spitzbarth I; Baumgärtner W; Beineke A
Vet Immunol Immunopathol; 2012 Jun; 147(1-2):6-24. PubMed ID: 22542984
[TBL] [Abstract][Full Text] [Related]
8. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
Stolp HB; Dziegielewska KM
Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
[TBL] [Abstract][Full Text] [Related]
10. Is damage in central nervous system due to inflammation?
Chavarria A; Alcocer-Varela J
Autoimmun Rev; 2004 Jun; 3(4):251-60. PubMed ID: 15246020
[TBL] [Abstract][Full Text] [Related]
11. The emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disorders.
Bushell T
J Physiol; 2007 May; 581(Pt 1):7-16. PubMed ID: 17347265
[TBL] [Abstract][Full Text] [Related]
12. CNS penetration of small molecules following local inflammation, widespread systemic inflammation or direct injury to the nervous system.
Lu P; Gonzales C; Chen Y; Adedoyin A; Hummel M; Kennedy JD; Whiteside GT
Life Sci; 2009 Sep; 85(11-12):450-6. PubMed ID: 19632245
[TBL] [Abstract][Full Text] [Related]
13. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
Larochelle C; Alvarez JI; Prat A
FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of the blood-brain barrier: animal models and methods.
Hawkins BT; Egleton RD
Curr Top Dev Biol; 2008; 80():277-309. PubMed ID: 17950377
[TBL] [Abstract][Full Text] [Related]
15. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?
Feng S; Huang Y; Chen Z
Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042
[TBL] [Abstract][Full Text] [Related]
16. The role of T helper cells in neuroprotection and regeneration.
Hendrix S; Nitsch R
J Neuroimmunol; 2007 Mar; 184(1-2):100-12. PubMed ID: 17198734
[TBL] [Abstract][Full Text] [Related]
17. Chronic systemic IL-1β exacerbates central neuroinflammation independently of the blood-brain barrier integrity.
Murta V; Farías MI; Pitossi FJ; Ferrari CC
J Neuroimmunol; 2015 Jan; 278():30-43. PubMed ID: 25595250
[TBL] [Abstract][Full Text] [Related]
18. Microglia in health and disease.
Kim SU; de Vellis J
J Neurosci Res; 2005 Aug; 81(3):302-13. PubMed ID: 15954124
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system.
Toft-Hansen H; Babcock AA; Millward JM; Owens T
J Neuroinflammation; 2007 Sep; 4():24. PubMed ID: 17883829
[TBL] [Abstract][Full Text] [Related]
20. [Blood-brain barrier and blood-nerve barrier in neuroinflammatory diseases].
Maeda T; Kanda T
Nihon Rinsho; 2013 May; 71(5):789-94. PubMed ID: 23777083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
